European Union and GSK Signs Deal to Supply Potential Covid-19 Drug
The European Union and GlaxoSmithKline (GSK) has recently signed a contract for the purpose of supplying around 220,000 treatments of the European Union’s monoclonal antibody therapy against the novel corona virus. According to the European Commission, the covid-19 drug, that has been developed together with the company Vir Biotechnology based in the United States can […]
Continue Reading